FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2801096810> ?p ?o ?g. }

• W2801096810 endingPage "e0195357" @default.
• W2801096810 startingPage "e0195357" @default.
• W2801096810 abstract "Background RV1001 is a novel, potent, and selective PI3Kδ inhibitor. The purpose of this study was to evaluate the safety and efficacy of RV1001 in canine Non-Hodgkin lymphoma (NHL). Methods and results Inhibition of endogenous pAKT by RV1001 in primary canine NHL cells was determined by Western blotting. A phase I study of RV1001 was performed in 21 dogs with naïve and drug resistant T and B-cell NHL to assess safety, pharmacokinetic profile, and response to therapy. The objective response rate was 62% (complete response (CR) n = 3; partial response (PR) n = 10), and responses were observed in both naïve and chemotherapy-resistant B and T cell NHL. This study provided the recommended starting dose for a phase II, non-pivotal, exploratory, open label multi-centered clinical trial in 35 dogs with naïve and drug resistant T and B-cell NHL, to further define the efficacy and safety profile of RV1001. The objective response rate in the phase II study was 77% (CR n = 1; PR n = 26). Clinical toxicities were primarily hepatobiliary and gastrointestinal, and were responsive to dose modifications and/or temporary drug discontinuation. Hepatotoxicity was the primary dose limiting toxicity. Conclusions RV1001 exhibits good oral bioavailability, an acceptable safety profile, and biologic activity with associated inhibition of pAKT in dogs with B and T cell NHL. Data from these studies can be leveraged to help inform the design of future studies involving isoform-selective PI3K inhibitors in humans." @default.
• W2801096810 created "2018-05-17" @default.
• W2801096810 creator A5010020323 @default.
• W2801096810 creator A5016151359 @default.
• W2801096810 creator A5021474295 @default.
• W2801096810 creator A5050909584 @default.
• W2801096810 creator A5056442329 @default.
• W2801096810 creator A5071115612 @default.
• W2801096810 creator A5075536148 @default.
• W2801096810 creator A5076590865 @default.
• W2801096810 creator A5082019123 @default.
• W2801096810 creator A5082255146 @default.
• W2801096810 creator A5085046088 @default.
• W2801096810 date "2018-04-24" @default.
• W2801096810 modified "2023-09-30" @default.
• W2801096810 title "Phase I/II evaluation of RV1001, a novel PI3Kδ inhibitor, in spontaneous canine lymphoma" @default.
• W2801096810 cites W1968852924 @default.
• W2801096810 cites W1980040544 @default.
• W2801096810 cites W1980705784 @default.
• W2801096810 cites W1992477322 @default.
• W2801096810 cites W1998288336 @default.
• W2801096810 cites W2015512041 @default.
• W2801096810 cites W2017607493 @default.
• W2801096810 cites W2019325963 @default.
• W2801096810 cites W2025786205 @default.
• W2801096810 cites W2027971058 @default.
• W2801096810 cites W2030439968 @default.
• W2801096810 cites W2031885687 @default.
• W2801096810 cites W2035916624 @default.
• W2801096810 cites W2038053631 @default.
• W2801096810 cites W2039160810 @default.
• W2801096810 cites W2040414600 @default.
• W2801096810 cites W2044931406 @default.
• W2801096810 cites W2066564017 @default.
• W2801096810 cites W2080877772 @default.
• W2801096810 cites W2087002438 @default.
• W2801096810 cites W2096807858 @default.
• W2801096810 cites W2098166849 @default.
• W2801096810 cites W2106374896 @default.
• W2801096810 cites W2109367246 @default.
• W2801096810 cites W2118217667 @default.
• W2801096810 cites W2121740832 @default.
• W2801096810 cites W2123666692 @default.
• W2801096810 cites W2129914893 @default.
• W2801096810 cites W2134861285 @default.
• W2801096810 cites W2143790526 @default.
• W2801096810 cites W2146647803 @default.
• W2801096810 cites W2163577434 @default.
• W2801096810 cites W2166337170 @default.
• W2801096810 cites W2166470267 @default.
• W2801096810 cites W2167746858 @default.
• W2801096810 cites W2179186936 @default.
• W2801096810 cites W2566021416 @default.
• W2801096810 cites W2573719758 @default.
• W2801096810 cites W4247428402 @default.
• W2801096810 cites W57072567 @default.
• W2801096810 doi "https://doi.org/10.1371/journal.pone.0195357" @default.
• W2801096810 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5915681" @default.
• W2801096810 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29689086" @default.
• W2801096810 hasPublicationYear "2018" @default.
• W2801096810 type Work @default.
• W2801096810 sameAs 2801096810 @default.
• W2801096810 citedByCount "12" @default.
• W2801096810 countsByYear W28010968102018 @default.
• W2801096810 countsByYear W28010968102019 @default.
• W2801096810 countsByYear W28010968102020 @default.
• W2801096810 countsByYear W28010968102021 @default.
• W2801096810 countsByYear W28010968102022 @default.
• W2801096810 countsByYear W28010968102023 @default.
• W2801096810 crossrefType "journal-article" @default.
• W2801096810 hasAuthorship W2801096810A5010020323 @default.
• W2801096810 hasAuthorship W2801096810A5016151359 @default.
• W2801096810 hasAuthorship W2801096810A5021474295 @default.
• W2801096810 hasAuthorship W2801096810A5050909584 @default.
• W2801096810 hasAuthorship W2801096810A5056442329 @default.
• W2801096810 hasAuthorship W2801096810A5071115612 @default.
• W2801096810 hasAuthorship W2801096810A5075536148 @default.
• W2801096810 hasAuthorship W2801096810A5076590865 @default.
• W2801096810 hasAuthorship W2801096810A5082019123 @default.
• W2801096810 hasAuthorship W2801096810A5082255146 @default.
• W2801096810 hasAuthorship W2801096810A5085046088 @default.
• W2801096810 hasBestOaLocation W28010968101 @default.
• W2801096810 hasConcept C111113717 @default.
• W2801096810 hasConcept C112705442 @default.
• W2801096810 hasConcept C126322002 @default.
• W2801096810 hasConcept C143998085 @default.
• W2801096810 hasConcept C181389837 @default.
• W2801096810 hasConcept C197934379 @default.
• W2801096810 hasConcept C2778715236 @default.
• W2801096810 hasConcept C2779338263 @default.
• W2801096810 hasConcept C2780035454 @default.
• W2801096810 hasConcept C2908752941 @default.
• W2801096810 hasConcept C29730261 @default.
• W2801096810 hasConcept C31760486 @default.
• W2801096810 hasConcept C535046627 @default.
• W2801096810 hasConcept C71924100 @default.
• W2801096810 hasConcept C98274493 @default.
• W2801096810 hasConceptScore W2801096810C111113717 @default.

• next